• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[抗凝血酶III——持久微血管手术中的一个重要因素]

[Antithrombin III--an important factor in long-lasting microvascular operations].

作者信息

Partecke B D, Fischer C, Buck-Gramcko D

出版信息

Handchir Mikrochir Plast Chir. 1985 Mar;17(2):81-5.

PMID:3988155
Abstract

Antithrombin III is an important factor in preventing thrombosis in the normal coagulation system. The antithrombotic effect of heparin is closely related to the presence of Antithrombin III (AT III) as cofactor. It is also known that the concentration of AT III decreases considerably during long-lasting gynaecological procedures and in visceral surgery. We have found that the serum concentration of AT III also decreases during long-lasting microvascular procedures as in free flap or toe transfers. The crucial points are the duration of the operation, the duration of ischaemia of the extremity and the preoperative concentration of AT III which heavily depends on the general condition of the patient. In ten cases the AT III concentration decreased by an average of 21.7%. In three patients the AT III factor decreased below the critical level of 80%. In these cases levels between 60 and 65% were measured at the end of long microvascular operations. This decrease of AT III can be avoided by application of the AT III factor in an active form during the procedure (AT III in solution with heparin). To avoid thrombosis of the anastomosed vessels the local application of AT III in its active form before anastomosis has proved very effective. In practice, measuring of the AT III level has proved to be very useful in long microvascular procedures before the operation and at intervals of two to four hours. Nevertheless, in spite of AT III application careful microsurgical anastomosis has to be made.

摘要

抗凝血酶III是正常凝血系统中预防血栓形成的重要因素。肝素的抗血栓作用与作为辅因子的抗凝血酶III(AT III)的存在密切相关。还已知在长期妇科手术和腹部手术期间,AT III的浓度会显著降低。我们发现,在诸如游离皮瓣或足趾移植等长期微血管手术期间,血清AT III浓度也会降低。关键因素是手术持续时间、肢体缺血持续时间以及术前AT III浓度,而术前AT III浓度很大程度上取决于患者的一般状况。在10例患者中,AT III浓度平均降低了21.7%。在3例患者中,AT III因子降至临界水平80%以下。在这些病例中,长时间微血管手术后测得的水平在60%至65%之间。在手术过程中应用活性形式的AT III因子(与肝素混合的溶液中的AT III)可以避免AT III的这种降低。为避免吻合血管血栓形成,在吻合前局部应用活性形式的AT III已证明非常有效。在实践中,已证明在长时间微血管手术前及手术期间每隔两到四小时测量AT III水平非常有用。然而,尽管应用了AT III,仍必须进行精细的显微外科吻合。

相似文献

1
[Antithrombin III--an important factor in long-lasting microvascular operations].[抗凝血酶III——持久微血管手术中的一个重要因素]
Handchir Mikrochir Plast Chir. 1985 Mar;17(2):81-5.
2
Venous thrombosis after microvascular free-tissue transfer in head and neck cancer reconstruction.头颈部癌症重建中微血管游离组织移植后的静脉血栓形成。
Auris Nasus Larynx. 2008 Sep;35(3):390-6. doi: 10.1016/j.anl.2007.10.005. Epub 2008 Jan 31.
3
Microsurgical free flap and replantation without antithrombotic agents.无需抗血栓药物的显微外科游离皮瓣移植与再植术。
J Med Assoc Thai. 2004 Jun;87(6):665-9.
4
[Microsurgical reconstruction of the upper extremity. Experience with 24 free flaps].[上肢的显微外科重建。24例游离皮瓣的经验]
Acta Med Port. 1998 Mar;11(3):227-37.
5
[Surgery of abdominal aorta with horseshoe kidney].马蹄肾腹主动脉手术
Srp Arh Celok Lek. 1997 Jan-Feb;125(1-2):36-44.
6
[Antithrombin III in hip surgery].[髋关节手术中的抗凝血酶III]
Z Orthop Ihre Grenzgeb. 1984 Jan-Feb;122(1):16-9. doi: 10.1055/s-2008-1044577.
7
[Antithrombin III deficiency as a risk factor in postoperative thrombosis].
Acta Chir Belg. 1985 Sep-Oct;85(5):299-302.
8
Effect of continuous low-dose intravenous heparin administered during operation on postoperative measurements of antithrombin III and antifactor Xa.手术期间持续静脉输注低剂量肝素对术后抗凝血酶III及抗Xa因子测量结果的影响
Surgery. 1984 Sep;96(3):550-5.
9
The effect of postoperative anticoagulation on microvascular thrombosis.术后抗凝对微血管血栓形成的影响。
Ann Plast Surg. 2007 Jul;59(1):36-9; discussion 39-40. doi: 10.1097/01.sap.0000264837.15110.2f.
10
[Prophylactic use of concentrated antithrombin III preparation in children with nephrotic syndrome].[浓缩抗凝血酶III制剂在肾病综合征患儿中的预防性应用]
Nihon Jinzo Gakkai Shi. 1993 Oct;35(10):1163-9.